Xoma reported $94.38M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Agenus USD 169.66M 146.06M Dec/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Ardelyx USD 202.83M 696K Dec/2025
aTyr Pharma USD 12.51M 12.11M Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 40.87B 5.6M Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Incyte USD 30.2M 5.17M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Prothena USD 0 0 Dec/2024
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Xoma USD 94.38M 7.82M Sep/2025